Fig. 1
From: Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types
The expression of SLC31A1 in normal tissues and different tumors. a Consensus SLC31A1 tissue expression based on the consensus dataset in HPA. The X-axis shows tissue or organ types. The Y-axis shows the SLC31A1 mRNA expression level. nTPM, normalized transcripts per million. b The protein expression stare of SLC31A1 in different tissues. The X-axis shows tissues or organ types. The Y-axis shows the SLC31A1 protein expression level. c The expression status of SLC31A1 in different tumor types is visualized by TIMER2. The Y-axis shows the SLC31A1 expression level in Log2 (TPM + 1). d–f The correlation between the relative abundance of protein and mRNA of SLC31A1 in liver cancer, lung squamous cell carcinoma, and ovarian cancer, respectively. g, h Comparison of SLC31A1 protein expression in tumor tissues and adjacent normal tissues from patients with liver cancer and stomach cancer. *P < 0.05; **P < 0.01; ***P < 0.001; ****, P < 0.0001